These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
176 related items for PubMed ID: 37355738
1. Glucocorticoid signature of preterm infants developing bronchopulmonary dysplasia. Romijn M, Onland W, van Keulen BJ, Heijboer AC, Rotteveel J, van Kaam AH, Finken MJJ. Pediatr Res; 2023 Nov; 94(5):1804-1809. PubMed ID: 37355738 [Abstract] [Full Text] [Related]
2. Efficacy and safety of systemic hydrocortisone for the prevention of bronchopulmonary dysplasia in preterm infants: a systematic review and meta-analysis. Morris IP, Goel N, Chakraborty M. Eur J Pediatr; 2019 Aug; 178(8):1171-1184. PubMed ID: 31144162 [Abstract] [Full Text] [Related]
3. Inhalation or instillation of steroids for the prevention of bronchopulmonary dysplasia. Bassler D. Neonatology; 2015 Aug; 107(4):358-9. PubMed ID: 26044104 [Abstract] [Full Text] [Related]
4. Breast-Milk Cortisol and Cortisone Concentrations Follow the Diurnal Rhythm of Maternal Hypothalamus-Pituitary-Adrenal Axis Activity. van der Voorn B, de Waard M, van Goudoever JB, Rotteveel J, Heijboer AC, Finken MJ. J Nutr; 2016 Nov; 146(11):2174-2179. PubMed ID: 27629575 [Abstract] [Full Text] [Related]
13. Systemic Hydrocortisone To Prevent Bronchopulmonary Dysplasia in preterm infants (the SToP-BPD study): statistical analysis plan. Onland W, Merkus MP, Nuytemans DH, Jansen-van der Weide MC, Holman R, van Kaam AH, SToP-BPD study group. Trials; 2018 Mar 09; 19(1):178. PubMed ID: 29523175 [Abstract] [Full Text] [Related]
14. Prophylaxis of early adrenal insufficiency to prevent bronchopulmonary dysplasia: a multicenter trial. Watterberg KL, Gerdes JS, Cole CH, Aucott SW, Thilo EH, Mammel MC, Couser RJ, Garland JS, Rozycki HJ, Leach CL, Backstrom C, Shaffer ML. Pediatrics; 2004 Dec 09; 114(6):1649-57. PubMed ID: 15574629 [Abstract] [Full Text] [Related]
15. Monocyte signature as a predictor of chronic lung disease in the preterm infant. Windhorst AC, Heydarian M, Schwarz M, Oak P, Förster K, Frankenberger M, Gonzalez Rodriguez E, Zhang X, Ehrhardt H, Hübener C, Flemmer AW, Hossain H, Stoeger T, Schulz C, Hilgendorff A. Front Immunol; 2023 Dec 09; 14():1112608. PubMed ID: 37090732 [Abstract] [Full Text] [Related]
16. Diseases associated with prematurity in correlation with N-terminal pro-brain natriuretic peptide levels during the early postnatal life. Fritz AS, Keller T, Kribs A, Hünseler C. Eur J Pediatr; 2023 Jul 09; 182(7):3075-3082. PubMed ID: 37072630 [Abstract] [Full Text] [Related]
17. Systemic Hydrocortisone To Prevent Bronchopulmonary Dysplasia in preterm infants (the SToP-BPD study); a multicenter randomized placebo controlled trial. Onland W, Offringa M, Cools F, De Jaegere AP, Rademaker K, Blom H, Cavatorta E, Debeer A, Dijk PH, van Heijst AF, Kramer BW, Kroon AA, Mohns T, van Straaten HL, te Pas AB, Theyskens C, van Weissenbruch MM, van Kaam AH. BMC Pediatr; 2011 Nov 09; 11():102. PubMed ID: 22070744 [Abstract] [Full Text] [Related]
18. Vitamin D and bronchopulmonary dysplasia in preterm infants. Joung KE, Burris HH, Van Marter LJ, McElrath TF, Michael Z, Tabatabai P, Litonjua AA, Weiss ST, Christou H. J Perinatol; 2016 Oct 09; 36(10):878-82. PubMed ID: 27467562 [Abstract] [Full Text] [Related]
19. Ceramides in tracheal aspirates of preterm infants: Marker for bronchopulmonary dysplasia. van Mastrigt E, Zweekhorst S, Bol B, Tibboel J, van Rosmalen J, Samsom JN, Kroon AA, de Jongste JC, Reiss IKM, Post M, Pijnenburg MW. PLoS One; 2018 Oct 09; 13(1):e0185969. PubMed ID: 29346372 [Abstract] [Full Text] [Related]